We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+26.41%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.88B
AUM Growth
+$2.09B
(+31%)
Cap. Flow
+$564M
Cap. Flow
% of AUM
6.36%
Top 10 Holdings %
Top 10 Hldgs %
40.05%
Holding
908
New
100
Increased
273
Reduced
455
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$76.1M |
| 2 |
Enterprise Products Partners
EPD
|
+$64.2M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$44.1M |
| 4 |
MPLX
MPLX
|
+$22M |
| 5 |
Plains All American Pipeline
PAA
|
+$21.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$23.3M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$21.9M |
| 3 |
Eastman Chemical
EMN
|
+$21.3M |
| 4 |
Duke Energy
DUK
|
+$20.8M |
| 5 |
Broadcom
AVGO
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 48.15% |
| 2 | Financials | 11.06% |
| 3 | Technology | 6.82% |
| 4 | Healthcare | 5.49% |
| 5 | Industrials | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
XPEL
XPEL
$1.18B
| $492K | 0.01% |
9,543
-290
| -3% | -$10.5K |
|
502
Protara Therapeutics
TARA
$227M
| $486K | 0.01% |
+20,070
| New | +$433K |
|
503
Parker-Hannifin
PH
$124B
| $482K | 0.01% |
1,768
+191
| +12% | +$47.3K |
|
504
Voyager Therapeutics
VYGR
$187M
| $479K | 0.01% |
67,021
+19,291
| +40% | +$185K |
|
505
Aldeyra Therapeutics
ALDX
$95.3M
| $475K | 0.01% |
+69,170
| New | +$486K |
|
506
Enel Chile
ENIC
$6.05B
| $475K | 0.01% |
121,988
+5,348
| +5% | +$19.1K |
|
507
Wipro
WIT
$18.9B
| $475K | 0.01% |
168,156
-21,512
| -11% | -$55.5K |
|
|
ENIA
508
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $470K | 0.01% |
+57,180
| New | +$417K |
|
509
Dr. Reddy's Laboratories
RDY
$9.8B
| $466K | 0.01% |
+32,700
| New | +$440K |
|
510
Western Alliance Bancorporation
WAL
$9.04B
| $461K | 0.01% |
7,698
-234
| -3% | -$11.4K |
|
|
KDNY
511
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $459K | 0.01% |
28,941
+8,240
| +40% | +$124K |
|
512
Abbott
ABT
$182B
| $458K | 0.01% |
4,180
+501
| +14% | +$54.5K |
|
513
Credicorp
BAP
$31.1B
| $458K | 0.01% |
+2,790
| New | +$387K |
|
514
Coca-Cola Femsa
KOF
$22.9B
| $452K | 0.01% |
9,798
-556
| -5% | -$24.2K |
|
|
PARA
515
DELISTED
Paramount Global Class B
PARA
| $452K | 0.01% |
12,122
+3,160
| +35% | +$101K |
|
516
Yeti Holdings
YETI
$3.86B
| $451K | 0.01% |
6,592
+341
| +5% | +$20.2K |
|
517
MYR Group
MYRG
$5.75B
| $447K | 0.01% |
7,440
-226
| -3% | -$11.2K |
|
518
Santander
BSBR
$40.7B
| $441K | 0.01% |
+53,317
| New | +$353K |
|
|
GTLS
519
DELISTED
Chart Industries
GTLS
| $438K | ﹤0.01% |
3,720
-113
| -3% | -$10.9K |
|
|
BPMP
520
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $438K | ﹤0.01% |
41,344
-230
| -0.6% | -$2.41K |
|
521
ITT
ITT
$17.7B
| $436K | ﹤0.01% |
5,667
+527
| +10% | +$36.8K |
|
522
O-I Glass
OI
$1.41B
| $435K | ﹤0.01% |
36,541
-4,771
| -12% | -$54.4K |
|
523
T. Rowe Price
TROW
$25.5B
| $435K | ﹤0.01% |
2,875
+263
| +10% | +$37.6K |
|
524
Darling Ingredients
DAR
$9.62B
| $432K | ﹤0.01% |
7,487
-228
| -3% | -$10.9K |
|
|
KZR
525
DELISTED
Kezar Life Sciences
KZR
| $432K | ﹤0.01% |
+8,282
| New | +$461K |
|
Similar funds
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, ALPS Advisors held 908 positions worth $8.88B, up 31% from $6.79B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
ALPS Advisors deployed $564M of net new capital in Q4 2020, opening 100 new positions and adding to 273 existing holdings. Its largest new stake was Genuine Parts: 212,300 shares worth $21.3M.
By sector, the portfolio is most concentrated in Energy at 48% of assets, up from 46% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was WestRock Company, an estimated $23.3M trimmed.
- ALPS Advisors's largest Q4 2020 buy was Genuine Parts: 212,300 shares worth $21.3M.
- ALPS Advisors added most to Energy Transfer Partners in Q4 2020, an estimated $76.1M increase.
- ALPS Advisors's biggest Q4 2020 reduction was WestRock Company, cutting an estimated $23.3M.
- ALPS Advisors fully exited Duke Energy in Q4 2020, selling an estimated $20.8M.
- ALPS Advisors's ten largest holdings make up 40% of its $8.88B portfolio in Q4 2020.
- ALPS Advisors opened 100 new positions and closed 75 in Q4 2020.
- ALPS Advisors's portfolio value rose 31% quarter-over-quarter to $8.88B.
Based on ALPS Advisors's 13F filing for Q4 2020, filed 3 Feb 2021.